SPAC IPO Update — October 29, 2026
1 SPAC IPO priced on October 29, 2026, raising $100M; October MTD now stands at 6 IPOs totaling $691M over 29 sessions.
SPAC IPO Count
Month-to-date: 6 IPOs ($691M) vs. first 29 days of last month 5 ($940M) · 12-mo avg: 16/mo
$ totals include underwriter over-allotment.
Bhav Acquisition Corp II is targeting industries such as quantum computing, energy, and power infrastructure, emphasizing high barriers to entry and technological moats. The management team brings significant expertise in navigating complex regulatory environments.
| Date | Ticker | Issuer | IPO Size | Trust Funding |
|---|---|---|---|---|
| Oct 29 | BHAI | BHAV Acquisition Corp II | $100M | 100.5% |
| Oct 27 | SCQC | SPACCircle Acquisition Corp. | $100M | 100.5% |
Daily SPAC Update — October 29, 2026
EXTENSION VOTES
CLIMATEROCK (CLRCF)vote October 29, 2026 -> extend from November 2, 2026 to May 2, 2027
STELLAR V CAPITAL CORP (CAYMAN ISLANDS) (SVCC)vote October 29, 2026 -> extend from October 31, 2026 to July 31, 2027
COPLEY ACQUISITION CORP (COPL)vote October 29, 2026 -> extend from November 2, 2026 to November 2, 2027
SPAC EXTENSIONS
WINTERGREEN ACQUISITION CORP (WTG) * Extension FilingWintergreen extended its business-combination deadline to November 30, 2026, with its sponsor providing a $184,635 non-interest-bearing note to fund the extension.
OTHER SPAC NEWS
INFLECTION POINT ACQUISITION CORP VII (IPXG) * Merger Agreement AmendmentInflection Point and Elroy Air amended their merger agreement, revising equity conversions, incentive-plan limits, financial-statement deadlines, and lock-up requirements.
SPAC LISTING RULE NOTICES
EUREKA ACQUISITION CORP (EURK) * Listing Rule NoticeNasdaq granted Eureka Acquisition Corp. until January 31, 2027, to regain compliance with its public-float listing requirement.
SPAC DEALS ANNOUNCED
October 26 | Amanat Acquisition Corp (AMAN) + Corxel PharmaceuticalsCorxel Pharmaceuticals is a clinical-stage biopharmaceutical company that develops oral medicines for obesity and related cardiometabolic conditions. Its lead product candidate, CX11, is a once-daily oral GLP-1 receptor agonist that has completed Phase 2 clinical development in the United States and Phase 3 clinical development in Asia. The company is also advancing CX12, an investigational oral amylin receptor agonist currently in preclinical development.
SPAC Movers — October 29, 2026
| Company | Ticker | Change | Price | Stage |
|---|---|---|---|---|
| RF ACQUISITION CORP II | RFAI | 37.0% | $ 35.83 | Announced |
| RIBBON ACQUISITION CORP | RIBB | 18.3% | $ 6.71 | Announced |
| FUTURE VISION II ACQUISITION CORP | FVN | 5.4% | $ 11.75 | Announced |
| QUETTA ACQUISITION CORP | QETA | 3.1% | $ 11.55 | Announced |
| RISING DRAGON ACQUISITION CORP | RDAC | 2.7% | $ 5.03 | Announced |
| Company | Ticker | Change | Price | Stage |
|---|---|---|---|---|
| CALISA ACQUISITION CORP | ALIS | -8.5% | $ 8.20 | Announced |
| MELAR ACQUISITION CORP I | MACI | -7.1% | $ 10.22 | Announced |
| TCGX ACQUISITION CORP II | TCXB | -2.1% | $ 10.27 | Pre-Deal |
| AI INFRASTRUCTURE ACQUISITION CORP | AIIA | -1.3% | $ 10.22 | Pre-Deal |
| BOLD EAGLE ACQUISITION CORP | BEAG | -1.2% | $ 10.39 | Announced |
Frequently Asked Questions
-
How many SPAC IPOs priced in October 2026 through October 29?6 SPAC IPOs priced for $691M through October 29, 2026, compared with 5 IPOs for $940M over the same 29-day span in September 2026.
-
What was BHAI‘s initial trust funding percentage?BHAV ACQUISITION CORP II (BHAI) listed 100.5% initial trust funding for its October 29, 2026 IPO.
-
What did IPXG change in its Elroy Air merger agreement?Inflection Point Acquisition Corp VII (IPXG) and Elroy Air revised equity conversions, incentive-plan limits, financial-statement deadlines and lock-up requirements.
-
Which SPACs held extension votes today?